Company Filing History:
Years Active: 2003-2004
Title: The Innovative Contributions of Jonas Fägerhag
Introduction
Jonas Fägerhag is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address clinical conditions associated with insulin resistance. With a total of 2 patents to his name, Fägerhag's work is recognized for its potential therapeutic applications.
Latest Patents
Fägerhag's latest patents include "Tri-substituted phenyl derivatives and analogues." This invention relates to specific tri-substituted phenyl derivatives and analogues, which are useful in treating conditions linked to insulin resistance. The patent outlines a process for preparing these compounds, methods for their therapeutic use, and pharmaceutical compositions that incorporate them. Another significant patent is for "Phenalkyloxy-phenyl derivatives," which further showcases his innovative approach to pharmaceutical development.
Career Highlights
Jonas Fägerhag is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on research and development in the pharmaceutical sector, contributing to advancements in drug formulation and therapeutic solutions.
Collaborations
Fägerhag has collaborated with several talented individuals in his field, including Eva-Lotte Lindstedt Alstermark and Lanna Li. These collaborations have fostered a creative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Jonas Fägerhag's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in treatments for insulin resistance and other clinical conditions.